Related Experiment Videos

Waldenström's macroglobulinemia associated with glioblastoma. A case report

E Lamaida1, F Caputi, A Rapanà

  • 1Neurosurgical Department, Ospedale S. Luca, Vallo della Lucania, Italie.

Revue Neurologique
|October 1, 1996
PubMed

Insights

Waldenström Macroglobulinemia (WM) can affect the central nervous system (CNS). This rare association with glioblastoma warrants further investigation into potential etiopathological links.

Area of Science:

  • Neuro-oncology
  • Hematology
  • Neuropathology

Background:

  • Waldenström Macroglobulinemia (WM) is a rare lymphoproliferative disorder.
  • Central Nervous System (CNS) involvement occurs in approximately 10% of WM patients.
  • Leptomeningeal lymphoplasmacytic infiltrates are the most commonly reported CNS manifestation.

Observation:

  • CNS involvement in WM presents a more complex clinical and histopathological picture than previously recognized.
  • Co-occurrence of WM with glioblastoma is exceptionally rare, with only three prior cases documented.
  • This case series explores the potential non-coincidental association between WM and glioblastoma.

Findings:

  • The study discusses the potential etiopathological links between Waldenström Macroglobulinemia and glioblastoma.
  • Analysis of rare co-occurrences suggests possible shared underlying mechanisms.
  • Histopathological examination reveals a variegated CNS damage pattern beyond simple leptomeningeal infiltration.

Implications:

  • Understanding these rare associations may offer new insights into CNS oncogenesis.
  • Further research is needed to elucidate the shared pathways between WM and glioblastoma.
  • This highlights the importance of considering diverse CNS pathologies in WM patients.

Related Concept Videos